Clozapine Augmented With Risperidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
- 1 January 2005
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 162 (1) , 130-136
- https://doi.org/10.1176/appi.ajp.162.1.130
Abstract
OBJECTIVE: The authors evaluated the efficacy and safety of augmenting clozapine with risperidone in patients with treatment-resistant schizophrenia. METHOD: In a randomized, double-blind, placebo-...Keywords
This publication has 30 references indexed in Scilit:
- Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinationsActa Psychiatrica Scandinavica, 2002
- Clozapine–Risperidone Combination in Treatment-Resistant SchizophreniaAustralian & New Zealand Journal of Psychiatry, 2001
- An open trial of risperidone augmentation of partial response to clozapineSchizophrenia Research, 2001
- Adjunctive Risperidone Treatment in Patients with ‘Clozapine-Resistant Schizophrenia’Australian & New Zealand Journal of Psychiatry, 2000
- A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory SchizophreniaNew England Journal of Medicine, 1997
- Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapineBiological Psychiatry, 1997
- Limitations of controlled augmentation trials in schizophreniaBiological Psychiatry, 1997
- Risperidone Augmentation of ClozapinePharmacopsychiatry, 1995
- Duration of a Clozapine Trial in Neuroleptic-Resistant SchizophreniaArchives of General Psychiatry, 1989
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988